CRVL
CRVL
CorVel CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $235.63M ▼ | $22.68M ▲ | $24.17M ▼ | 10.26% ▼ | $0.47 ▼ | $40.08M ▼ |
| Q2-2026 | $239.64M ▲ | $22.28M ▲ | $27.91M ▲ | 11.64% ▲ | $0.54 ▲ | $43.74M ▲ |
| Q1-2026 | $234.71M ▲ | $21.48M ▼ | $27.23M ▲ | 11.6% ▲ | $0.53 ▲ | $42.87M ▲ |
| Q4-2025 | $231.51M ▲ | $24.65M ▲ | $26.42M ▲ | 11.41% ▲ | $0.51 ▲ | $40.92M ▲ |
| Q3-2025 | $227.97M | $22.06M | $23.77M | 10.43% | $0.46 | $38.3M |
What's going well?
The company remains profitable with no debt burden, and overhead is well-contained. Earnings are clean with no unusual items distorting results.
What's concerning?
Revenue is shrinking, margins are under pressure, and profits are down compared to last quarter. Operating expenses are rising even as sales fall, signaling efficiency issues.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $230.03M ▲ | $644.78M ▲ | $269.06M ▲ | $375.72M ▲ |
| Q2-2026 | $207.45M ▲ | $611.68M ▲ | $248.9M ▼ | $362.78M ▲ |
| Q1-2026 | $202.03M ▲ | $597.45M ▲ | $254.92M ▲ | $342.53M ▲ |
| Q4-2025 | $170.58M ▲ | $545.98M ▲ | $223.99M ▼ | $321.99M ▲ |
| Q3-2025 | $162.94M | $538.78M | $237.93M | $300.85M |
What's financially strong about this company?
CRVL has more cash than debt, a very high equity cushion, and a long history of profits. Liquidity is excellent, and the company is even buying back shares.
What are the financial risks or weaknesses?
Payables and accrued expenses are rising, which could signal some working capital pressure. There’s also a moderate amount of lease obligations, but nothing alarming.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $24.17M ▼ | $46.14M ▲ | $-10.97M ▼ | $-12.59M ▼ | $22.58M ▲ | $35.17M ▲ |
| Q2-2026 | $27.91M ▲ | $25.02M ▼ | $-9.75M ▲ | $-9.84M ▼ | $5.43M ▼ | $15.27M ▼ |
| Q1-2026 | $27.23M ▲ | $55.01M ▲ | $-15.46M ▼ | $-8.11M ▼ | $31.44M ▲ | $39.55M ▲ |
| Q4-2025 | $26.42M ▲ | $22.92M ▼ | $-8.66M ▲ | $-6.62M ▲ | $7.64M ▼ | $14.26M ▼ |
| Q3-2025 | $23.77M | $41.65M | $-9.54M | $-7.52M | $24.59M | $32.11M |
What's strong about this company's cash flow?
CRVL's operations are throwing off more cash each quarter, with free cash flow more than doubling this period. The company is self-funding, buying back shares, and building a large cash reserve.
What are the cash flow concerns?
Much of this quarter's cash surge came from working capital timing, which may not repeat. Net income dipped, and if working capital swings the other way, cash flow could drop.
Revenue by Products
| Product | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
Network Solutions Services | $80.00M ▲ | $90.00M ▲ | $90.00M ▲ | $90.00M ▲ |
Patient Management Services | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CorVel Corporation's financial evolution and strategic trajectory over the past five years.
CorVel combines steady growth with improving profitability, a conservative and cash‑rich balance sheet, and strong cash generation. Its integrated technology platform, extensive provider network, and purposeful investment in specialized staff give it a differentiated position in workers’ compensation and risk management. The company’s financial structure — low leverage, rising equity, and robust free cash flow — provides resilience and flexibility to keep investing in its platform and returning capital through buybacks.
Key risks include the increasingly competitive and technology‑driven nature of the insurance services market, where larger players and new tech entrants are investing heavily in similar tools. The lack of a separate R&D line item raises questions about whether innovation spending is sufficiently protected and monitored. Operationally, rising capital expenditures and ongoing share repurchases could become a strain if cash generation slows. Regulatory changes in healthcare, workers’ compensation, or data usage could also impact the business model and margins.
The overall picture suggests a company with positive momentum, sound financial underpinnings, and a focused strategy built around technology‑enabled risk management services. If CorVel continues to execute on its innovation roadmap, maintain its service quality, and manage capital prudently, it appears well positioned to sustain growth and profitability. At the same time, its future trajectory will depend on its ability to keep its technology and talent base ahead of a fast‑moving competitive and regulatory environment.
About CorVel Corporation
https://www.corvel.comCorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $235.63M ▼ | $22.68M ▲ | $24.17M ▼ | 10.26% ▼ | $0.47 ▼ | $40.08M ▼ |
| Q2-2026 | $239.64M ▲ | $22.28M ▲ | $27.91M ▲ | 11.64% ▲ | $0.54 ▲ | $43.74M ▲ |
| Q1-2026 | $234.71M ▲ | $21.48M ▼ | $27.23M ▲ | 11.6% ▲ | $0.53 ▲ | $42.87M ▲ |
| Q4-2025 | $231.51M ▲ | $24.65M ▲ | $26.42M ▲ | 11.41% ▲ | $0.51 ▲ | $40.92M ▲ |
| Q3-2025 | $227.97M | $22.06M | $23.77M | 10.43% | $0.46 | $38.3M |
What's going well?
The company remains profitable with no debt burden, and overhead is well-contained. Earnings are clean with no unusual items distorting results.
What's concerning?
Revenue is shrinking, margins are under pressure, and profits are down compared to last quarter. Operating expenses are rising even as sales fall, signaling efficiency issues.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $230.03M ▲ | $644.78M ▲ | $269.06M ▲ | $375.72M ▲ |
| Q2-2026 | $207.45M ▲ | $611.68M ▲ | $248.9M ▼ | $362.78M ▲ |
| Q1-2026 | $202.03M ▲ | $597.45M ▲ | $254.92M ▲ | $342.53M ▲ |
| Q4-2025 | $170.58M ▲ | $545.98M ▲ | $223.99M ▼ | $321.99M ▲ |
| Q3-2025 | $162.94M | $538.78M | $237.93M | $300.85M |
What's financially strong about this company?
CRVL has more cash than debt, a very high equity cushion, and a long history of profits. Liquidity is excellent, and the company is even buying back shares.
What are the financial risks or weaknesses?
Payables and accrued expenses are rising, which could signal some working capital pressure. There’s also a moderate amount of lease obligations, but nothing alarming.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $24.17M ▼ | $46.14M ▲ | $-10.97M ▼ | $-12.59M ▼ | $22.58M ▲ | $35.17M ▲ |
| Q2-2026 | $27.91M ▲ | $25.02M ▼ | $-9.75M ▲ | $-9.84M ▼ | $5.43M ▼ | $15.27M ▼ |
| Q1-2026 | $27.23M ▲ | $55.01M ▲ | $-15.46M ▼ | $-8.11M ▼ | $31.44M ▲ | $39.55M ▲ |
| Q4-2025 | $26.42M ▲ | $22.92M ▼ | $-8.66M ▲ | $-6.62M ▲ | $7.64M ▼ | $14.26M ▼ |
| Q3-2025 | $23.77M | $41.65M | $-9.54M | $-7.52M | $24.59M | $32.11M |
What's strong about this company's cash flow?
CRVL's operations are throwing off more cash each quarter, with free cash flow more than doubling this period. The company is self-funding, buying back shares, and building a large cash reserve.
What are the cash flow concerns?
Much of this quarter's cash surge came from working capital timing, which may not repeat. Net income dipped, and if working capital swings the other way, cash flow could drop.
Revenue by Products
| Product | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
Network Solutions Services | $80.00M ▲ | $90.00M ▲ | $90.00M ▲ | $90.00M ▲ |
Patient Management Services | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CorVel Corporation's financial evolution and strategic trajectory over the past five years.
CorVel combines steady growth with improving profitability, a conservative and cash‑rich balance sheet, and strong cash generation. Its integrated technology platform, extensive provider network, and purposeful investment in specialized staff give it a differentiated position in workers’ compensation and risk management. The company’s financial structure — low leverage, rising equity, and robust free cash flow — provides resilience and flexibility to keep investing in its platform and returning capital through buybacks.
Key risks include the increasingly competitive and technology‑driven nature of the insurance services market, where larger players and new tech entrants are investing heavily in similar tools. The lack of a separate R&D line item raises questions about whether innovation spending is sufficiently protected and monitored. Operationally, rising capital expenditures and ongoing share repurchases could become a strain if cash generation slows. Regulatory changes in healthcare, workers’ compensation, or data usage could also impact the business model and margins.
The overall picture suggests a company with positive momentum, sound financial underpinnings, and a focused strategy built around technology‑enabled risk management services. If CorVel continues to execute on its innovation roadmap, maintain its service quality, and manage capital prudently, it appears well positioned to sustain growth and profitability. At the same time, its future trajectory will depend on its ability to keep its technology and talent base ahead of a fast‑moving competitive and regulatory environment.

CEO
Michael G. Combs
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-12-26 | Forward | 3:1 |
| 2013-06-27 | Forward | 2:1 |
ETFs Holding This Stock
IJR.AX
Weight:0.10%
Shares:1.90M
VTS.AX
Weight:0.00%
Shares:887.64K
SPSM
Weight:0.10%
Shares:291.96K
Summary
Showing Top 3 of 196
Ratings Snapshot
Rating : B+
Price Target
Institutional Ownership
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Shares:5.45M
Value:$281.52M
BLACKROCK, INC.
Shares:4.79M
Value:$247.58M
VANGUARD GROUP INC
Shares:3.29M
Value:$169.76M
Summary
Showing Top 3 of 362

